Literature DB >> 6544797

In vivo validation of a cell culture test for biocompatibility testing of urinary catheters.

D T Graham, G E Mark, A R Pomeroy, E B Macarthur.   

Abstract

Biocompatibility tests have been compared for their suitability as routine safety tests for urinary catheters. Latex catheters from five manufacturers were tested by each of the following four methods: (1) a cell culture cytotoxicity assay of catheter extracts, (2) intracutaneous injection of the extracts into rabbits, (3) intramuscular implant of catheter pieces into rabbits, (4) catheterization of sheep (mucous membrane irritation). The rabbit intracutaneous and intramuscular tests are both current pharmacopoeial methods for ascertaining the suitability of polymers for medical use. The four tests each showed a cell or tissue response ranging from no detectable change to severe damage, according to the catheter batch or brand, and they each identified the same samples as most toxic and least toxic. However, they differed in sensitivity. The sheep test and the cell culture assay discriminated between catheters of intermediate toxicity and ranked as toxic catheters not identified as such by the two pharmacopoeial tests. The sheep test most closely approximates clinical usage, but is impractical for routine use. The cell culture assay is a suitable alternative. It also has the advantages of a clearly defined endpoint, good sensitivity, reproducibility, speed, and reduced animal usage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6544797     DOI: 10.1002/jbm.820180914

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  2 in total

1.  Blood circulation in the urethra during hypovolemia--an experimental study.

Authors:  M Talja; T Schröder; A Lehtola; P Nuutinen; M Ruutu; O Alfthan
Journal:  Urol Res       Date:  1986

2.  Evaluation of the extraction method for the cytotoxicity testing of latex gloves.

Authors:  Hyun Sook Baek; Ja Young Yoo; Dong Kyun Rah; Dong-Wook Han; Dong Hee Lee; Oh-Hun Kwon; Jong-Chul Park
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.